BABA vs RUSHA

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

RUSHA exhibits strong operational health with a Piotroski F-Score of 7/9, indicating a robust financial foundation. However, the stock is significantly overvalued, trading at $73.93 despite a Graham Number of $46.02 and an Intrinsic Value of $22.89. While the company has an exceptional track record of beating earnings estimates over 25 quarters, current YoY revenue and earnings growth have turned negative (-11.8% and -11.0% respectively). The combination of a strong balance sheet and consistent execution is currently offset by expensive valuation metrics and bearish insider sentiment.